Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 5 studies | 51% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 42% | 699.25 | 151 / 359 | 68% | 1.40 | 195 / 286 |
intestine | 44% | 554.19 | 425 / 966 | 64% | 1.45 | 335 / 527 |
esophagus | 36% | 755.47 | 526 / 1445 | 68% | 1.77 | 125 / 183 |
prostate | 16% | 319.33 | 38 / 245 | 88% | 3.15 | 440 / 502 |
muscle | 100% | 48492.39 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 21271.54 | 854 / 861 | 0% | 0 | 0 / 0 |
ovary | 4% | 38.06 | 7 / 180 | 86% | 2.53 | 370 / 430 |
breast | 3% | 49.00 | 15 / 459 | 85% | 2.56 | 950 / 1118 |
pancreas | 3% | 21.54 | 9 / 328 | 81% | 2.42 | 144 / 178 |
blood vessel | 83% | 2551.81 | 1111 / 1335 | 0% | 0 | 0 / 0 |
brain | 15% | 151.18 | 402 / 2642 | 52% | 1.04 | 369 / 705 |
lung | 4% | 51.60 | 24 / 578 | 60% | 1.79 | 697 / 1155 |
adrenal gland | 5% | 41.97 | 14 / 258 | 53% | 1.34 | 123 / 230 |
bladder | 10% | 81.00 | 2 / 21 | 48% | 1.16 | 240 / 504 |
uterus | 6% | 60.80 | 11 / 170 | 47% | 3.07 | 214 / 459 |
lymph node | 0% | 0 | 0 / 0 | 45% | 0.94 | 13 / 29 |
skin | 21% | 425.52 | 386 / 1809 | 21% | 0.65 | 98 / 472 |
liver | 0% | 0 | 0 / 226 | 27% | 0.68 | 111 / 406 |
eye | 0% | 0 | 0 / 0 | 24% | 0.90 | 19 / 80 |
thymus | 1% | 16.49 | 5 / 653 | 20% | 0.64 | 119 / 605 |
tonsil | 0% | 0 | 0 / 0 | 20% | 0.66 | 9 / 45 |
kidney | 0% | 0 | 0 / 89 | 14% | 0.40 | 122 / 901 |
adipose | 4% | 39.07 | 47 / 1204 | 0% | 0 | 0 / 0 |
spleen | 1% | 6.82 | 2 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 12.06 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003242 | Biological process | cardiac chamber ballooning |
GO_0055003 | Biological process | cardiac myofibril assembly |
GO_0030017 | Cellular component | sarcomere |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0003875 | Molecular function | ADP-ribosylarginine hydrolase activity |
Gene name | ADPRHL1 |
Protein name | ADP-ribosylhydrolase like 1 Inactive ADP-ribosyltransferase ARH2 (ADP-ribosylhydrolase-like protein 1) ([Protein ADP-ribosylarginine] hydrolase-like protein 1) |
Synonyms | ARH2 |
Description | FUNCTION: Required for myofibril assembly and outgrowth of the cardiac chambers in the developing heart (By similarity). Appears to be catalytically inactive, showing no activity against O-acetyl-ADP-ribose (By similarity). . |
Accessions | ENST00000356501.8 [Q8NDY3-2] Q8NDY3 A0A804HI13 X6RL45 ENST00000682618.1 ENST00000612156.3 ENST00000413169.2 ENST00000375418.8 [Q8NDY3-1] A0A0U1RQK4 |